Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma.
Ontology highlight
ABSTRACT: Asthma is a chronic lung disease that has a high prevalence. The therapeutic intervention of this disease can be made more effective if genetic variability in patients' response to medications is implemented. However, a clear picture of the genetic architecture of asthma intervention response remains elusive. We conducted a genome-wide association study (GWAS) to identify drug response-associated genes for asthma, in which 909 622 SNPs were genotyped for 120 randomized participants who inhaled multiple doses of glucocorticoids. By integrating pharmacodynamic properties of drug reactions, we implemented a mechanistic model to analyze the GWAS data, enhancing the scope of inference about the genetic architecture of asthma intervention. Our pharmacodynamic model observed associations of genom
SUBMITTER: Wang Y
PROVIDER: S-EPMC6156797 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA